These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2071269)

  • 61. Comparative bioavailability of slow release dicbfenac (Voveran SR) with enteric coated tablet and internationally used Voltaren retard.
    Kumar PD
    J Assoc Physicians India; 1992 Jul; 40(7):483. PubMed ID: 1484038
    [No Abstract]   [Full Text] [Related]  

  • 62. In vitro evaluation of dissolution properties and degradation products of omeprazole in enteric-coated pellets.
    Storpirtis S; Rodrigues D
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1101-7. PubMed ID: 9876567
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative bioavailability of diclofenac hydroxyethylpyrrolidine vs diclofenac sodium in man.
    Maggi CA; Lualdi P; Mautone G
    Eur J Clin Pharmacol; 1990; 38(2):207-8. PubMed ID: 2338120
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The bioavailability of ofloxacin from several formulations.
    Flor S; Beals B
    Curr Med Res Opin; 1991; 12(5):282-6. PubMed ID: 2004540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications.
    Ngo SN; Barnes T
    Int J Pharm Pract; 2010 Aug; 18(4):245-8. PubMed ID: 20636678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bioavailability of hydrocortisone from commercial 20-mg tablets.
    Patel RB; Rogge MC; Selen A; Goehl TJ; Shah VP; Prasad VK; Welling PG
    J Pharm Sci; 1984 Jul; 73(7):964-6. PubMed ID: 6470962
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Formulation and biopharmaceutical evaluation of osmotic matrix tablets of diclofenac sodium.
    Rani M; Surana R; Sankar C; Mishra B
    Drug Deliv; 2004; 11(4):263-70. PubMed ID: 15371108
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteers.
    Chan KK; Mojaverian P; Ziehmer BA; John VA
    Pharm Res; 1990 Oct; 7(10):1026-32. PubMed ID: 2281031
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Study on the interaction between sucralfate and diclofenac/piroxicam in healthy volunteers.
    Ungethüm W
    Arzneimittelforschung; 1991 Aug; 41(8):797-800. PubMed ID: 1781800
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bioequivalency of ranitidine tablets.
    Alkaysi HN; Salem MA; Gharaibeh AM; el-Sayed YM; Ali-Gharaibeh KI; Badwan AA
    J Clin Pharm Ther; 1989 Apr; 14(2):111-7. PubMed ID: 2722974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.
    DiSanto AR; Chodos DJ; Phillips JP; DeSante KA; Stoll RG
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):220-7. PubMed ID: 950266
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions.
    Risha PG; Vervaet C; Vergote G; Bortel LV; Remon JP
    Eur J Clin Pharmacol; 2003 Jun; 59(2):135-41. PubMed ID: 12721773
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stability, bioavailability, and ulcerative activity of diclofenac sodium-mastic controlled release tablets.
    Nouh AT; Abd El-Gawad AH; Guda TK
    Drug Discov Ther; 2010 Apr; 4(2):93-9. PubMed ID: 22491166
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biopharmaceutical profile of diclofenac-misoprostol combination tablet, Arthrotec.
    Karim A; Smith M
    Scand J Rheumatol Suppl; 1992; 96():37-48. PubMed ID: 1439623
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Eight enteric-coated 50 mg diclofenac sodium tablet formulations marketed in Saudi Arabia: in vitro quality evaluation.
    Hammami MM; Hussein RF; AlSwayeh R; Alvi SN
    BMC Res Notes; 2020 Sep; 13(1):428. PubMed ID: 32928294
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bioavailability of different brands of tetracycline in undernourished subjects.
    Santosh KK; Raghuram TC; Krishnaswamy K
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):13-7. PubMed ID: 1551739
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of dual radiotelemetric technique in studying drug-drug interaction between diclofenac sodium and ranitidine HCl in volunteers.
    Alioth C; Blum RA; D'Andrea DT; Kochak GM; Teng L; Ziehmer BA; Schentag JJ; Chan KK
    Pharm Res; 1993 Nov; 10(11):1688-92. PubMed ID: 8290486
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products.
    Mostafa HF; Ibrahim MA; Mahrous GM; Sakr A
    Saudi Pharm J; 2011 Apr; 19(2):123-7. PubMed ID: 23960750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans.
    Straughn AB; Wood GC; Raghow G; Meyer MC
    J Pharm Sci; 1985 Mar; 74(3):335-7. PubMed ID: 4009445
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.
    McNamara PJ; Foster TS; Digenis GA; Patel RB; Craig WA; Welling PG; Rapaka RS; Prasad VK; Shah VP
    Pharm Res; 1987 Apr; 4(2):150-3. PubMed ID: 3509139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.